Ping An Capital

Ping An Insurance (Group) Company of China, Ltd. is a leading integrated financial services provider based in Shenzhen, established in 1988. The company operates across multiple sectors, including life and health insurance, property and casualty insurance, banking, asset management, and technology services. Its life and health insurance segment offers various products such as term and whole-life insurance, while the property and casualty segment provides auto and accident insurance. The banking division handles loans, wealth management, and credit card services. Additionally, Ping An engages in trust services, investment banking, and asset management. The firm emphasizes innovation by integrating financial services into everyday life, striving for a comprehensive platform that enhances customer experience. Ping An Capital, its venture capital arm, focuses on early-stage investments in sectors such as financial technology, healthcare, and environmental protection. The company is committed to sustainable growth and aims to provide long-term returns to its shareholders.

Zhang Jiang

Managing Director

Zhongzhi Li

Board Member and Managing Director

Mingzhe Ma

Founder, Chairman and Board Member

Sun Shufeng

Managing Director

Sun Yong

Managing Director

Arowana Yu

Managing Director

Hui Zhou

Partner

Chris Zhu

Partner

Tian Tuo Ph.D

Managing Director

124 past transactions

Soterea

Series B in 2022
Soterea mainly develops safe driving solutions and data service products for commercial vehicles.

RainMed

Series D in 2021
Rain Med is a vascular interventional surgical robot developer focused on the development of coronary angiography systems.

Xgene Pharmaceutical

Series C in 2021
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.

Biren Technology

Series B in 2021
Biren Technology, based in Shanghai, China, specializes in the design and manufacture of intelligent chips and processors tailored for various computing architectures, including GPU and DSA. The company operates in the high-tech sector, focusing on both hardware and software solutions. Its hardware division develops a range of computing solutions that blend versatility with specificity, while its software department is led by experienced industry professionals. The company also conducts frontier research on new intelligent computing systems, emphasizing innovative architectures and advanced compilation technologies. Biren Technology aims to provide integrated solutions for applications such as cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing, enabling clients to utilize domestic chip solutions and achieve significant technological advancements.

Apollomics

Series C in 2020
Apollomics is a developer of oncology therapeutics intend to harness the immune system and targeting specific molecular pathways.The company's therapeutics target the growth and proliferation of cancer cells and offer an oral c-Met inhibitor that restores the body's immune system to recognize and kill cancer cells, enabling clients to treat their patients in an enhanced way.

Lepu Bio

Series B in 2020
Lepu Biotechnology Co., Ltd. is a China-based biotech company specializing in tumor immunotherapy. Founded in 2018, it has developed an industrial platform that facilitates the discovery, development, and manufacturing of innovative drug candidates. The company's core offerings include programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) antibodies, an oncolytic virus, and various antibody-drug conjugates (ADCs). These products have advanced into clinical stages I to III, highlighting the company's commitment to advancing cancer treatment through its proprietary technologies.

Wind

Funding Round in 2019
Wind Information is recognized as the leading firm in financial data, information services and solutions in China. We are dedicated to providing accurate and real-time data, as well as sophisticated information platforms for financial professionals.

Lixiangjia

Series D in 2019
The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high net worth families. Professional overseas asset reconfiguration plan.

Shijiazhuang Junlebao Dairy

Funding Round in 2019
Shijiazhuang Junlebao Dairy is a prominent dairy products company based in China, specializing in a diverse array of offerings that include fluid milks, flavored milk, yogurt, baby formula, and milk powder. The company has developed a comprehensive operational framework that encompasses the entire dairy industry chain, ensuring coordinated development and a focus on nutrition, health, and safety for its consumers. By prioritizing quality and innovation, Junlebao Dairy aims to meet the growing demand for dairy products in the market while promoting the well-being of its customers.

ITutorGroup

Acquisition in 2019
ITutorGroup provides online education platforms for students and business professionals. Its products include VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English-language learning, TutorMing for Mandarin Chinese language learning, and LiveH2H for live translations in multiple languages. Eric Yang, Jerry Huang, and Ming Yang founded ITutorGroup in 1998, with headquarters in Taipei City in Taiwan. It has additional offices in Shanghai in China and Santa Clara in California.
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Global Data Solutions Limited is a data center operator based in Shanghai, China, with additional facilities in Beijing, Chengdu, Shenzhen, Kunshan, and Guangzhou. Founded in 2000 by William Wei Huang, the company specializes in designing, building, and managing data centers, providing services such as colocation, managed hosting, and managed cloud solutions. It offers information technology outsourcing services, including business continuity and disaster recovery, which encompass planning, design, implementation, and operation. The company primarily serves clients in the Internet and banking sectors, as well as a range of industries including finance, energy, manufacturing, aviation, telecommunications, and large corporations, both domestic and multinational. Global Data Solutions aims to deliver high-quality infrastructure and support to enhance operational efficiency and reliability for its diverse customer base across the Asia-Pacific region.

Zhangshang Tangyi

Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xiaoqule

Series A in 2018
Xiaoqule is a community-focused e-commerce platform based in Hangzhou, China, and operates as a subsidiary of Zhejiang Gejia Network Technology Co., Ltd. The platform connects local businesses with consumers, facilitating the purchase of cost-effective products and services, including seasonal fruits and vegetables, imported snacks, and group ordering options. By shortening transportation times and ensuring the quality of goods, Xiaoqule enhances the shopping experience for local communities. Additionally, Xiaoqule provides logistical support, encompassing transportation, technology, marketing, and customer service, thereby enabling users to interact with their communities while conveniently fulfilling their purchasing needs.

Global Scanner

Series A in 2018
Global Scanner is provider of imported food products.

NextCure

Series B in 2018
NextCure, Inc. is a clinical-stage biopharmaceutical company based in Beltsville, Maryland, dedicated to discovering and developing innovative immunomedicines for cancer and other immune-related diseases. The company’s lead product candidate, NC318, is currently undergoing Phase 2 clinical trials aimed at treating advanced or metastatic solid tumors. Additionally, NextCure is advancing NC410, an immunomedicine designed to counteract immune suppression through targeting an immune modulator known as Leukocyte-Associated Immunoglobulin-like Receptor 1. The company is also engaged in research programs evaluating novel immunomodulatory molecules, including antibodies in preclinical development that target specific immune modulators in inflamed tissues and tumor microenvironments. NextCure has established a license agreement with Yale University and collaborates with Eli Lilly and Company for research and development efforts. Founded in 2015, the company leverages proprietary platforms to identify biologically relevant targets and develop first-in-class immunotherapy products.

Xgene Pharmaceutical

Series B in 2018
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Jin Jiang Environmental Holdings Limited is China's leading waste to energy operators.The company has successfully embarked on a road of environmentally-friendly energy industrialization that combines production, learning

Grab

Series H in 2018
Grab Holdings Inc., based in Singapore, is a prominent mobile technology platform operating in Southeast Asia. Founded in 2012, the company offers a wide range of services, including ride-sharing through GrabTaxi and GrabCar, and food and grocery delivery. Grab also provides financial services, such as payments, consumer loans, and insurance, catering to both merchants and consumers. Its platform connects drivers and customers, generating revenue primarily through commissions from ride-sharing and food delivery services. Grab operates in eight countries, including Singapore, Indonesia, and Malaysia, where it holds a significant market share. The company has expanded its offerings to include various options for transportation and delivery, as well as a mobile wallet for seamless transactions. Grab continues to face competition from other regional players, such as Foodpanda and Gojek.

Chemclin

Private Equity Round in 2018
Beijing Chemclin Biotech Co., Ltd. specializes in the development, production, and sales of diagnostic reagents and instruments for clinical use. Founded in 1999 and based in Beijing, China, the company focuses on in-vitro diagnostics, offering a range of products including reagents for infectious diseases, tumor markers, and thyroid and diabetes testing. Chemclin also provides semi-automated and fully automated chemiluminescent analyzers, which facilitate the performance of chemiluminescent assays. Additionally, the company offers commercial testing services for various health conditions, including liver fibrosis and fertility. As a subsidiary of China Diagnostics Medical Corporation, Chemclin is committed to delivering innovative diagnostic solutions and services to the Chinese healthcare market.

Grab

Series H in 2018
Grab Holdings Inc., based in Singapore, is a prominent mobile technology platform operating in Southeast Asia. Founded in 2012, the company offers a wide range of services, including ride-sharing through GrabTaxi and GrabCar, and food and grocery delivery. Grab also provides financial services, such as payments, consumer loans, and insurance, catering to both merchants and consumers. Its platform connects drivers and customers, generating revenue primarily through commissions from ride-sharing and food delivery services. Grab operates in eight countries, including Singapore, Indonesia, and Malaysia, where it holds a significant market share. The company has expanded its offerings to include various options for transportation and delivery, as well as a mobile wallet for seamless transactions. Grab continues to face competition from other regional players, such as Foodpanda and Gojek.

Grab

Series H in 2018
Grab Holdings Inc., based in Singapore, is a prominent mobile technology platform operating in Southeast Asia. Founded in 2012, the company offers a wide range of services, including ride-sharing through GrabTaxi and GrabCar, and food and grocery delivery. Grab also provides financial services, such as payments, consumer loans, and insurance, catering to both merchants and consumers. Its platform connects drivers and customers, generating revenue primarily through commissions from ride-sharing and food delivery services. Grab operates in eight countries, including Singapore, Indonesia, and Malaysia, where it holds a significant market share. The company has expanded its offerings to include various options for transportation and delivery, as well as a mobile wallet for seamless transactions. Grab continues to face competition from other regional players, such as Foodpanda and Gojek.

JollyChic

Series C in 2018
Jollychic EC Limited is an online retail platform that offers a diverse range of products, including clothing, shoes, bags, baby items, electronics, home goods, and various accessories. Established in 2012 and headquartered in Birkirkara, Malta, Jollychic aims to provide customers with a convenient shopping experience through its extensive selection of stylish and quality products. The platform features categories such as apparel, sports goods, toys, bedding, wedding supplies, cleaning tools, and kitchen appliances, making it a comprehensive destination for consumers seeking a variety of goods in one place.

Tmunity

Series A in 2018
Tmunity Therapeutics, based in Philadelphia and incorporated in 2015, is a bio-therapeutics company focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. The company specializes in engineering T cells, utilizing novel T Cell Receptor (TCR) technologies, regulatory T cells (Treg), and universal engineered T cell platforms to enhance the activation and direction of T cells in vivo. Tmunity's proprietary methodologies allow for the activation, expansion, and genetic engineering of T cells derived from peripheral blood, cord blood, and tumors. The founding team comprises experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, boasting a strong track record in conducting safe and effective cell and gene therapy trials. Additionally, Tmunity's manufacturing capabilities support multi-center clinical studies across various therapeutic areas, positioning the company to deliver next-generation personalized immunotherapies.

Hua Medicine

Series D in 2018
Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.

Rani Therapeutics

Venture Round in 2018
Rani Therapeutics, LLC, founded in 2012 and based in San Jose, California, specializes in developing oral biotherapeutics technologies for the delivery of large drug molecules, such as peptides, proteins, and antibodies. The company aims to provide a convenient alternative to traditional injection methods through its proprietary RaniPill capsule, which is designed to facilitate the oral administration of biologics. Rani Therapeutics offers a range of treatments targeting various health conditions, including TNF-alpha inhibitors for inflammatory disorders, parathyroid hormone for osteoporosis, and human growth hormone for growth deficiencies. Additionally, the company develops therapies for multiple sclerosis, type II diabetes, obesity, and other inflammatory diseases using its innovative oral delivery system.

TytoCare

Series C in 2018
TytoCare Ltd. is a healthcare technology company that develops handheld devices and applications for on-demand medical examinations and remote diagnoses. Founded in 2012 and based in Netanya, Israel, with an office in New York, the company offers three main telehealth products: TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote care settings. These tools enable users to conduct self-examinations of various health conditions, such as ear infections, respiratory issues, and abdominal pain, by assessing the heart, lungs, skin, throat, ears, and body temperature. The platform facilitates virtual consultations by connecting patients with healthcare professionals, allowing for diagnosis and prescriptions as needed. TytoCare's technology incorporates a cloud-based data repository, analytics, and machine learning algorithms to enhance user experience and diagnostic accuracy. The company has established a strategic partnership with Novant Health to further its mission of making healthcare accessible and convenient.

Tmunity

Series A in 2018
Tmunity Therapeutics, based in Philadelphia and incorporated in 2015, is a bio-therapeutics company focused on developing innovative immunotherapies for cancer, infectious diseases, and autoimmune disorders. The company specializes in engineering T cells, utilizing novel T Cell Receptor (TCR) technologies, regulatory T cells (Treg), and universal engineered T cell platforms to enhance the activation and direction of T cells in vivo. Tmunity's proprietary methodologies allow for the activation, expansion, and genetic engineering of T cells derived from peripheral blood, cord blood, and tumors. The founding team comprises experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, boasting a strong track record in conducting safe and effective cell and gene therapy trials. Additionally, Tmunity's manufacturing capabilities support multi-center clinical studies across various therapeutic areas, positioning the company to deliver next-generation personalized immunotherapies.

KBP Biosciences

Series A in 2018
KBP Biosciences Co., Ltd. is a biotechnology company based in Jinan, China, with additional offices in Beijing, Japan, and the United States. Founded in 2002, the company focuses on the research and development of drugs targeting infectious and metabolic diseases. Its comprehensive research platform employs structure-based drug design, in vitro and cell-based biological screening, and pharmacodynamic and pharmacokinetic evaluation, alongside ADME profiling and pre-clinical animal pharmacology and toxicity analysis. KBP Biosciences also offers services related to the transfer of new drugs, licensing, and intellectual property protection, which includes patent scope analysis, novelty analysis, and patent writing and filing. The organization is committed to delivering innovative therapies to address unmet medical needs.

Startup Health

Venture Round in 2018
StartUp Health is dedicated to improving global health and well-being through a long-term mission that spans 30 years. Since its inception in 2011, the organization has invested in a network of entrepreneurs termed Health Transformers, aiming to achieve significant health objectives known as health moonshots. These initiatives focus on critical areas such as access to care, reducing costs, curing diseases, enhancing women’s and children’s health, promoting nutrition and fitness, supporting mental health, addressing addiction, and preparing for pandemics. StartUp Health boasts the largest health innovation portfolio worldwide, comprising over 330 companies across six continents and 26 countries. The organization is supported by a diverse group of prominent investors from various sectors, reflecting a strong commitment to fostering innovation in healthcare.

Rogrand

Series C in 2017
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Chexiang

Series B in 2017
Chexiang is a Chinese online-to-offline automotive trading platform operated by Shanghai-based SAIC Motor Co. Ltd. The platform is designed to serve the automotive needs of consumers in China, offering services that include renting, buying, sharing, or booking vehicles at competitive prices. By facilitating these transactions, Chexiang aims to enhance the travel experience for its users, providing convenient access to various automotive options.

Fullerton Health

Venture Round in 2017
Fullerton Health is a prominent provider of corporate healthcare solutions in the Asia Pacific region. Headquartered in Singapore, the company operates over 225 fully-owned medical centers and has established a vast network of more than 8,000 medical providers. With a workforce of around 2,000 employees, including over 1,200 healthcare professionals, Fullerton Health is equipped to deliver a range of services. These services include managed care, network management, primary care, and secondary care, ensuring that patients have access to efficient and cost-effective healthcare. Additionally, the company supports its operations with six call centers across five countries, enhancing its service delivery and patient engagement.

Tikin Media

Angel Round in 2017
Tikin Media is a forward-looking advertising company that innovates building elevator media. The shareholders are composed of the world's top 500 and well-known media groups. They were successively invested by Baidu Venture Capital, Sequoia China and IDG within one year. Since its inception, the company has positioned itself to be a “high-end commercial building effect media operator”. The company's self-developed and possessed intellectual property elevator projection equipment is a new media form that subverts existing planar communication media, realizes mobile interconnection, and has programmatic ordering and big data analysis functions.

Annoroad

Series C in 2017
Annoroad Gene Technology Co. Ltd. provides clinical cytogenetic medical testing services for the development of a new genomics technology. The company was founded in 2012 and is based in Beijing, China.

Prenetics

Series B in 2017
Prenetics Limited is a DNA biotechnology company focused on genetic and diagnostic health testing. It specializes in pharmacogenomics through its iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles, also identifying potential adverse drug reactions. Additionally, Prenetics offers ONEdna, a DNA screening service that analyzes individual genes and provides actionable health recommendations. The company operates through its consumer brands, CircleDNA in Asia and DNAFit, empowering individuals with insights into their health risks, dietary needs, and responses to medications using simple saliva samples. Founded in 2007 and based in Central, Hong Kong, Prenetics has established strategic partnerships with organizations such as The Lippo Group and New Horizon Health Limited.

Huya

Series A in 2017
Huya Inc. operates a leading game live streaming platform in China, facilitating interactive broadcasts that allow real-time interaction between broadcasters and viewers. Founded in 2011 and headquartered in Guangzhou, Huya provides a diverse array of live streaming content, encompassing a vast library of approximately 3,800 games across various genres, including esports, mobile, and console games, as well as entertainment categories like talent shows and online theater. Additionally, Huya runs Nimo TV, which focuses on game streaming in Southeast Asia and Latin America. The company also engages in online advertising, marketing services, software development, and internet value-added services. As a subsidiary of Tencent, Huya benefits from the support of one of the largest technology companies in China, with Tencent holding a significant equity stake and voting power.

Aiqi Technology

Series A in 2017
Beijing AIQI Technology Co., Ltd. is an Internet technology company founded in 2013 and based in Beijing, China. The company specializes in the research and development of artificial intelligence and robotic technology, focusing on the creation of DIY intelligent robots. AIQI has developed a range of interactive robots aimed at K-12 STEM education, promoting human-machine interaction and creativity among users. In recent years, the company has secured numerous patents in intelligent equipment and established a partnership with the technology giant Xiaomi, becoming the sole provider of DIY intelligent robots within Xiaomi's ecosystem. With a strong research team and advanced production capabilities, AIQI Technology aims to deliver innovative and user-friendly robotic solutions that enhance modern life.

Global Switch

Secondary Market in 2016
Global Switch is a prominent operator of large-scale, carrier and cloud-neutral data centers, primarily serving clients across Europe and the Asia-Pacific region. Founded in 1998 and headquartered in London, the company manages a portfolio of thirteen multi-tenanted data centers that collectively offer approximately 390,000 square meters of technical space. These facilities are designed to accommodate various clients, including government organizations, financial institutions, and enterprises, providing essential services such as power and cooling, security, and infrastructure monitoring. Global Switch focuses on strategic locations that are resilient and low latency, situated near key financial and business districts to enhance connectivity and service delivery. The company is committed to delivering high-quality solutions and has established a strong reputation in the industry through its extensive experience and operational expertise.

TapTap

Series A in 2016
TapTap is a community game, is also a platform game download purchase.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibody drug candidates. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in treating multiple cancers and is featured on the National Reimbursement Drug List. Innovent has developed several other promising candidates, including biosimilars and bispecific antibodies for conditions such as non-Hodgkin’s lymphoma, autoimmune diseases, and advanced solid tumors. The company has established strategic collaborations with major global pharmaceutical firms, enhancing its research and development capabilities. Founded in 2011, Innovent has a strong management team with extensive experience in biologics, and it continues to expand its portfolio of therapeutic options while maintaining a commitment to innovation in the biopharmaceutical industry.

Gegejia

Series A in 2016
Gegejia, operated by Zhejiang Grid Network Technology Co., Ltd., is an e-commerce platform specializing in the sale of imported food products. Launched on March 26, 2015, the company quickly gained traction, processing over 10,000 orders within its first 30 days, generating millions in revenue. Gegejia partners with renowned international food brands to offer high-quality and carefully selected food items to Chinese consumers. The core team at Gegejia brings extensive e-commerce experience, with each member having between five to ten years in the industry, contributing to the company's strong resource network and operational expertise.

Nanopep

Seed Round in 2016
Nanoprep, a nano-biotech company, engages in research and development of products and services of precision medical technology for cancer treatment and prevention. The company is based in Beijing, China.
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Applied StemCell

Series D in 2016
Applied StemCell Inc. is a biotechnology company specializing in animal and cell line models that facilitate drug discovery and diagnostics. The company employs its proprietary TARGATT gene modification technology to efficiently create site-specific Knockin mouse, rat, and human cell line models, catering to both pharmaceutical and academic researchers. Applied StemCell focuses on developing and commercializing various models, including Knockin, Knockout, and Transgenic mouse models, humanized mouse models, and gene-modified human cell lines derived from induced pluripotent stem cells. Additionally, the company offers optimized stem cell culture products and gene engineering solutions for mammalian cells. By continuously enhancing its technologies and expanding its product offerings, Applied StemCell aims to support the evolving needs of the biomedical community and advance next-generation biomedical research.

Rogrand

Series B in 2016
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Shenchu Jiayan

Angel Round in 2016
Operator of an online restaurant ordering platform intended to provide users with dinner booking services. The company's platform allows users to review restaurant options to book their dinner and also enables restaurant chiefs to improve their supply chain efficiency by selecting high quality food ingredients.

F-ROAD

Series E in 2016
Shanghai F-road Commercial Services Co., Ltd. provides mobile financial services for financial institutions. The company offers a range of services, including encrypted mobile banking services, online day-to-day services, development and operation of community bank, asset management of regional banks, and Internet finance; and mobile banking solutions to regional banks. It offers its services through mobile terminals. Shanghai F-Road Commercial Services Co., Ltd. was founded in 2008 and is based in Shanghai, China.

Autohome

Acquisition in 2016
Autohome Inc. is the leading online destination for automobile consumers in China. Through their two websites, autohome.com.cn and che168.com, they provide comprehensive, independent and interactive content to automobile buyers and owners. Autohome.com.cn ranked first among China's automotive websites and automotive channels of internet portals in terms of average daily unique visitors, average daily time spent per user and average daily page views in 2013, according to iResearch, a third-party research firm. Their ability to reach a large and engaged user base of automobile consumers have made them the preferred platform for automakers and dealers to conduct their advertising campaigns. Automakers typically utilize their advertising services for brand promotion, new model releases and sales promotions. Their dealer subscription services allow dealers to market their inventory and services through their websites, extending the reach of their physical showrooms to potentially millions of internet users in China.

Meidaila

Series B in 2016
Developer of medical aesthetic community platform designed to share information in medical aesthetic industry. The company's platform mainly provides women with chat community, and question and answer service about plastic surgery.

Prenetics

Series A in 2016
Prenetics Limited is a DNA biotechnology company focused on genetic and diagnostic health testing. It specializes in pharmacogenomics through its iGenes PGx test, which assists physicians in determining the appropriate medication and dosage for patients based on their genetic profiles, also identifying potential adverse drug reactions. Additionally, Prenetics offers ONEdna, a DNA screening service that analyzes individual genes and provides actionable health recommendations. The company operates through its consumer brands, CircleDNA in Asia and DNAFit, empowering individuals with insights into their health risks, dietary needs, and responses to medications using simple saliva samples. Founded in 2007 and based in Central, Hong Kong, Prenetics has established strategic partnerships with organizations such as The Lippo Group and New Horizon Health Limited.

Fe3 Medical

Series B in 2016
Fe3 Medical, Inc., operating as Bria Medical, specializes in developing transdermal therapies specifically for iron deficiency anemia. The company has created a disposable transdermal patch designed to deliver about 10 milligrams of iron directly through the skin, effectively bypassing the gastrointestinal tract and minimizing side effects commonly associated with oral iron supplements. Primarily targeting women, Fe3 Medical aims to provide a safe and non-toxic alternative for those affected by iron deficiency. Established in 2008, the company is headquartered in San Antonio, Texas.

JMDNA

Series B in 2016
JMDNA (Shanghai) Bio-Medical Technology Co., Ltd. specializes in the research and application of molecular diagnostics. Established in 2011 and located in Shanghai, China, the company offers a range of services, including non-invasive genetic testing for women and children, as well as diagnostics for liver diseases and tumors. JMDNA is committed to facilitating the early diagnosis of hereditary diseases and other conditions, thereby improving healthcare outcomes for mothers and children.

Oscar Health

Private Equity Round in 2016
Oscar Health is a health insurance company that provides individual and family plans, Medicare Advantage, and small group products. Founded in 2012 and headquartered in New York, Oscar Health operates in several states, including New York, Texas, California, New Jersey, Ohio, and Tennessee. The company aims to enhance the healthcare experience by utilizing technology, design, and data to create user-friendly services. Its platform includes a software application that helps users find doctors based on location and ratings. Oscar Health primarily serves individuals and families who do not receive health insurance from their employers.

Bochewang

Series B in 2016
Provider of an online second-hand auction service platform designed to cater to the needs of car owners and buyers. The company's platform provide services ranging from second-hand car auctions to parts services and financial services, enabling car owners and buyers to conduct car transactions online with reduced time and increased efficiency.

20/20 GeneSystems

Series A in 2016
20/20 GeneSystems Inc. is a biotechnology company based in Rockville, Maryland, focused on developing and commercializing diagnostic tests for the early detection of cancer. The company offers several products, including PAULA’s Test, a blood test for lung cancer detection, and OneTest, which screens for multiple cancer types, such as lung, liver, and pancreatic cancers. Additionally, 20/20 provides BioCheck, a detection kit for screening suspicious powders, and Layered ImmunoHistoChemistry, which predicts the efficacy of targeted cancer therapies. The firm also offers CoronaCheck Tests, specializing in COVID-19 antibody testing. With a commitment to reducing cancer mortality, 20/20 GeneSystems employs advanced biomarker technologies and collaborates with various health agencies and organizations to enhance cancer diagnostics and promote personalized medicine.

Zhangshang Tangyi

Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xieche.com

Series B in 2016
Provider of automobile maintenance and repair services for car owners. The company's services include improving air conditioning efficiency, oil changes and cleaning the tire rims and at the same time educating customers about each maintenance process, enabling car owners to clean and maintain their cars as well as provide information transparency.

Alchemy Information

Angel Round in 2015
Provider of game art outsourcing services intended for game development companies. The company specializes in game art production and animation production for various game platforms, committed to providing self-developed high-quality game entertainment products for the global market.

Black & White Campus

Series A in 2015
Provider of a mobile social application designed to cater to the needs of students. The company's application offers an outlet for students to discuss and meet up for any given topic.

MOGU

Series E in 2015
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.

NCARS

Angel Round in 2015
Operator of automobile sales&service shops chain intended for high-end automotive maintenance. The company integrates brand marketing management, spare parts supply chain, technician training, service management and other technologies, the company provides machine repair, body painting, insurance, accident car rescue and other services, providing car owners with convenient and efficient automotive services.

Anxin Doctor

Series A in 2015
Anxin Doctor is a mobile healthcare platform focused on maternal and pediatric health. It connects patients with obstetricians, gynecologists, and pediatricians through its application, which facilitates access to healthcare advice and clinical appointment bookings. By bridging the gap between patients and healthcare professionals, Anxin Doctor aims to enhance health outcomes for mothers and children, ensuring timely and efficient medical care.

58 Daojia

Series A in 2015
58 Daojia operates an online multi-category household service platform in China, connecting users to various high-quality offline services such as cleaning, moving, babysitting, and beauty care. Established in September 2014, the platform utilizes a location-based order processing system to link customers with the nearest independent service providers. Serving approximately 30 cities across the country, 58 Daojia aims to enhance the convenience of home life by offering easy access to essential services through its user-friendly platform.

Zhangshang Tangyi

Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Clinicloud

Seed Round in 2015
CliniCloud, Inc. is a healthcare technology company based in San Francisco, California, that develops a connected medical kit aimed at empowering users to monitor various health indicators such as fever, cough, and respiratory conditions. Founded by physicians Dr. Hon Weng Chong and Dr. Andrew Lin, CliniCloud initially launched as "StethoCloud," featuring a smart stethoscope and later expanded its offerings to include a non-contact thermometer, recognizing the importance of temperature in diagnostics. The connected medical kit includes a digital stethoscope, a non-contact thermometer, and a mobile application that records high-fidelity audio, enabling users to track symptoms and share their health data with medical professionals for timely evaluations. CliniCloud aims to facilitate proactive health management and equip patients with the necessary tools for informed healthcare decisions, marking a shift towards more patient-centered care.

Ativa Medical

Series B in 2015
Ativa Medical Corporation is a medical device manufacturing company focused on developing and commercializing point of care testing diagnostic products tailored for decentralized healthcare settings. Founded in 2008 and headquartered in Saint Paul, Minnesota, the company specializes in providing analyzers that conduct essential hematology and clinical chemistry tests, along with disposable test cards designed for trauma, pediatric, oncology, and geriatric patients. Ativa Medical aims to deliver diagnostic test results in moments rather than hours or days, serving a diverse range of clients, including hospital departments, physician's offices, and remote healthcare clinics across the globe.

Ativa Medical

Series B in 2015
Ativa Medical Corporation is a medical device manufacturing company focused on developing and commercializing point of care testing diagnostic products tailored for decentralized healthcare settings. Founded in 2008 and headquartered in Saint Paul, Minnesota, the company specializes in providing analyzers that conduct essential hematology and clinical chemistry tests, along with disposable test cards designed for trauma, pediatric, oncology, and geriatric patients. Ativa Medical aims to deliver diagnostic test results in moments rather than hours or days, serving a diverse range of clients, including hospital departments, physician's offices, and remote healthcare clinics across the globe.

Payoneer

Series E in 2015
Payoneer Inc. operates a cross-border payments platform designed to facilitate global commerce by connecting businesses, professionals, countries, and currencies. Founded in 2005 and headquartered in New York, the company offers products such as the Global Payment Service, which provides users with local receiving accounts in the United States, European Union, and Japan, allowing for direct local bank transfers. Additionally, Payoneer enables users to receive payments from various integrated partners, including those in freelance, e-commerce, and online advertising sectors. The company also provides mass payout services that assist Indian companies in transferring funds internationally. Serving millions of users across over 200 countries, Payoneer is a trusted partner for numerous prominent corporations, making cross-border payments as straightforward as local transactions.
Beijing Express Channel Cold Chain Logistics Co., Ltd. is based in Beijing, China.

Didi

Private Equity Round in 2015
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation. Bo Zhang and Wei Cheng established the company in 2012 in Beijing, Beijing.

Secoo

Series E in 2015
Secoo Holding Limited operates a comprehensive online and offline shopping platform primarily in China, Hong Kong, and internationally. Founded in 2011 and headquartered in Beijing, the company offers a wide range of upscale products and services, including luxury bags, watches, clothing, cosmetics, and home goods, through its website, mobile applications, and physical experience centers. Additionally, Secoo serves as a marketplace for third-party merchants to sell their upscale products. The company's business model integrates offline stores with an online mall, facilitating direct sales to consumers. Secoo has established strategic partnerships, including an alliance with Parkson Group, and plans to expand its presence through exhibition centers in major cities. The majority of its revenue is generated from online sales, with a significant customer base that includes a large number of VIP members.

Bochewang

Series A in 2015
Provider of an online second-hand auction service platform designed to cater to the needs of car owners and buyers. The company's platform provide services ranging from second-hand car auctions to parts services and financial services, enabling car owners and buyers to conduct car transactions online with reduced time and increased efficiency.

Rogrand

Series A in 2015
Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Purple Clinic

Series A in 2015
Developer of a digital marketing project management platform designed to provide digital marketing service related to medical services. The company's platform provides an online medical mobile application, enabling doctors and patients to communicate with each other on consultation service in the fields of dermatology, pediatrics, gynecology, andrology and internal medicine.

Medbanks

Series A in 2015
Medbanks Network Technology Co. Ltd., founded in 2014 and headquartered in Beijing, China, provides data processing services tailored for the healthcare industry. The company specializes in developing a multi-center database that aggregates and analyzes data reflecting China's patient population. Additionally, Medbanks creates an oncology database that incorporates clinical and professional medical services based on information collected from hospitals. This focus on data management and analysis aims to enhance healthcare services and research in China.

eXiche

Series A in 2015
eXiche provide users with Internet booking to the shop car wash, door car wash services.

9F Group

Series B in 2015
9F Fintech Holdings Group is a Chinese Fintech platform and has more than 68 million registered users with most of them using 9F’s mobile applications. Founded in 2006, 9F is committed to offering its users with simple, efficient, high-quality and comprehensive financial services and aimed to create a wealth of values for its users through mobile Internet and Big Data risk management technologies. With its many brands such as 9F Onecard, 9F Wallet, Wukong Wealth, 9F Primasia Securities, 9FChaoneng (3C at POS), LabiFenqi (Education), and Wecash, 9F Group offers an extensive range of services that cover the various needs of its member life stages. In addition, through "Jiuchuang Fund," 9F has invested into over ten Internet finance start-ups to explore future technologies and developments. 9F was a founding member of National Internet Finance Association of China (NIFA) and elected to be a board member of NIFA. Sponsored by the People’s Bank of China, the China Banking Regulatory Commission (CBRC), China Securities Regulatory Commission (CSRC) and China Insurance Regulatory Commission (CIRC), NIFA was founded in Shanghai in March 2016.

Rainbow Medical

Venture Round in 2015
Rainbow Medical is a unique private operational company that seeds and grows companies developing breakthrough medical devices invented by Yossi Gross in a diverse range of medical fields. By addressing significant unmet market needs, Rainbow Medical seeks to generate exceptional returns for its investors.

WanJiangLong

Series A in 2015
Wuhan Wanjianglong Network Co., Ltd. is a company based in Wuhan, China, that specializes in designing and developing digital consumer service platforms for business and shopping centers. Founded in 2014, it offers a range of services, including the construction of commercial center platforms, back-end big data management, and intelligent operations powered by big data. Additionally, Wanjianglong provides software solutions that assist shopping center merchants in collecting and analyzing consumer data, enabling them to understand customer preferences better. This insight allows for the creation of tailored marketing strategies, helping merchants to expand their customer base and enhance sales performance.

Mogoroom

Series A in 2014
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.

eToro

Series D in 2014
eToro is a social trading investment network that facilitates financial trading by allowing users to observe and replicate the trading activities of others. Established in 2007 and headquartered in London, the platform aims to democratize access to global markets by providing tools for both manual and automated trading across various asset classes, including traditional investments and cryptocurrencies. Its key features include the OpenBook and WebTrader platforms, which enable users to share live trading insights and learn from one another. eToro's model fosters a collaborative environment where investors can leverage the expertise of their peers while making informed trading decisions. The company also maintains registered offices in Cyprus and Israel, operating as a subsidiary of eToro Group Limited.

Black & White Campus

Angel Round in 2014
Provider of a mobile social application designed to cater to the needs of students. The company's application offers an outlet for students to discuss and meet up for any given topic.

Payoneer

Series D in 2014
Payoneer Inc. operates a cross-border payments platform designed to facilitate global commerce by connecting businesses, professionals, countries, and currencies. Founded in 2005 and headquartered in New York, the company offers products such as the Global Payment Service, which provides users with local receiving accounts in the United States, European Union, and Japan, allowing for direct local bank transfers. Additionally, Payoneer enables users to receive payments from various integrated partners, including those in freelance, e-commerce, and online advertising sectors. The company also provides mass payout services that assist Indian companies in transferring funds internationally. Serving millions of users across over 200 countries, Payoneer is a trusted partner for numerous prominent corporations, making cross-border payments as straightforward as local transactions.

Xieche.com

Series A in 2014
Provider of automobile maintenance and repair services for car owners. The company's services include improving air conditioning efficiency, oil changes and cleaning the tire rims and at the same time educating customers about each maintenance process, enabling car owners to clean and maintain their cars as well as provide information transparency.

Lewanduo

Angel Round in 2014
Operator of a gaming platform intended to serve the entertainment sector in China. The company's platform offers real-time and multiplayer games for Android-based phones and desktops.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.